Draft 340B re­forms in­clude user fees, clar­i­ty around con­tract phar­ma­cies

Six bi­par­ti­san sen­a­tors sug­gest­ed sev­er­al changes to im­prove the “sta­bil­i­ty and trans­paren­cy” of the 340B drug dis­count pro­gram in a long-await­ed draft bill re­leased Fri­day.

The 340B pro­gram re­quires drug man­u­fac­tur­ers to of­fer dis­counts to cer­tain health sys­tems and hos­pi­tals serv­ing low-in­come pop­u­la­tions. But law­mak­ers have ac­cused some sys­tems of abus­ing the grow­ing pro­gram, while phar­ma com­pa­nies have set their own lim­its around par­tic­i­pa­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER